1. BDCA1+ cDC2s, BDCA2+ pDCs and BDCA3+ cDC1s reveal distinct pathophysiologic features and impact on clinical outcomes in melanoma patients. Issue 11 (24th November 2020) Authors: Sosa Cuevas, Eleonora; Ouaguia, Laurissa; Mouret, Stephane; Charles, Julie; De Fraipont, Florence; Manches, Olivier; Valladeau‐Guilemond, Jenny; Bendriss‐Vermare, Nathalie; Chaperot, Laurence; Aspord, Caroline Journal: Clinical & translational immunology Issue: Volume 9:Issue 11(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Diversification of circulating and tumor‐infiltrating plasmacytoid DCs towards the P3 (CD80+ PDL1−)‐pDC subset negatively correlated with clinical outcomes in melanoma patients. Issue 5 (3rd May 2022) Authors: Sosa Cuevas, Eleonora; Bendriss‐Vermare, Nathalie; Mouret, Stephane; De Fraipont, Florence; Charles, Julie; Valladeau‐Guilemond, Jenny; Chaperot, Laurence; Aspord, Caroline Journal: Clinical & translational immunology Issue: Volume 11:Issue 5(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dysfunctional BTN3A together with deregulated immune checkpoints and type I/II IFN dictate defective interplay between pDCs and γδ T cells in melanoma patients, which impacts clinical outcomes. Issue 11 (9th November 2021) Authors: Girard, Pauline; Sosa Cuevas, Eleonora; Ponsard, Benedicte; Mouret, Stephane; Gil, Hugo; Col, Edwige; De Fraipont, Florence; Sturm, Nathalie; Charles, Julie; Manches, Olivier; Chaperot, Laurence; Aspord, Caroline Journal: Clinical & translational immunology Issue: Volume 10:Issue 11(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The avidity of tumor‐specific T cells amplified by a plasmacytoid dendritic cell‐based assay can predict the clinical evolution of melanoma patients. (21st October 2017) Authors: Charles, Julie; Chaperot, Laurence; Revol, Bruno; Baudin, Marine; Mouret, Stephane; Hamon, Agnes; Leccia, Marie‐Therese; Plumas, Joel; Aspord, Caroline Journal: Pigment cell & melanoma research Issue: Volume 31:Number 1(2018) Page Start: 82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The features of circulating and tumor-infiltrating γδ T cells in melanoma patients display critical perturbations with prognostic impact on clinical outcome. (3rd August 2019) Authors: Girard, Pauline; Charles, Julie; Cluzel, Camille; Degeorges, Emmanuelle; Manches, Olivier; Plumas, Joel; De Fraipont, Florence; Leccia, Marie-Therese; Mouret, Stephane; Chaperot, Laurence; Aspord, Caroline Journal: Oncoimmunology Issue: Volume 8:Number 8(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. T‐cell receptor diversity as a prognostic biomarker in melanoma patients. (3rd February 2020) Authors: Charles, Julie; Mouret, Stephane; Challende, Isabelle; Leccia, Marie‐Therese; De Fraipont, Florence; Perez, Solene; Plantier, Nadia; Plumas, Joel; Manuel, Manuarii; Chaperot, Laurence; Aspord, Caroline Journal: Pigment cell & melanoma research Issue: Volume 33:Number 4(2020) Page Start: 612 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗